Medication info
Withers Glimepiride Tablet 2mg

Withers Glimepiride Tablet 2mg

Prescription medicationTabletOral
Ingredient · strength
Glimepiride›2mg / 1 tablet
Manufacturer / importer
Withers Pharmaceutical Co., Ltd.
Appearance
Green oval tablet
Packaging
30 tablets/bottle, 300 tablets/bottle
Approval status
Active

MFDS item code 200402823 · Notified 2004.09.30 · Insurance code 660701090

Summary

Main use
Improvement of glycemic control in type 2 diabetes mellitus
Who takes it
Adults
Adult dose
Adjust the dose individually for each patient. Swallow without chewing with at least 1/2 cup of water. This drug is administered orally once daily. This drug should be taken before breakfast or immediately before the first meal. It is very important not to skip a meal after taking this drug. 1. Monotherapy 1) Initial dose and dose titration In patients who have not previously received medication, initiate treatment with glimepiride 1 mg once daily. If necessary, increase the dose by 1 mg at intervals of 1 ~ 2 weeks. In general, doses above 4 mg provide little additional benefit, but some patients have achieved better metabolic control by increasing the dose to 6 mg (or 8 mg). If treatment with 4 mg daily is unsuccessful, first consider switching to insulin therapy; otherwise, consider combination treatment with insulin or another oral antidiabetic drug. 2) Subsequent dose adjustment As diabetes control may improve as treatment progresses, the requirement for this drug may decrease. Therefore, dose reduction or discontinuation of this drug may be necessary to avoid hypoglycemia. Dose adjustment should also be considered if weight loss, lifestyle changes, or other factors that may increase the risk of hypoglycemia or hyperglycemia occur. 3) Switching from another oral hypoglycemic agent to this drug There is no precise dose equivalence between this drug and other oral hypoglycemic agents. When switching from another oral hypoglycemic agent to this drug, it is recommended to follow the method described under Initial dose. That is, initiate treatment with 1 mg once daily and adjust the dose at 1 ~ 2-week intervals. Consider the potency and duration of action of the previously administered drug. 4) Dose monitoring During treatment with this drug, blood glucose and/or urine glucose levels should be measured regularly; regular measurement of glycosylated hemoglobin (HbA1c) levels is also recommended. In general, hypoglycemia is promptly controlled by immediate ingestion of sugar. Hypoglycemia may recur despite successful initial management during treatment with a sulfonylurea. Therefore, patients should be monitored carefully. Severe hypoglycemia requires immediate medical treatment and follow-up, and hospitalization is sometimes required. 2. Combination therapy 1) Combination therapy with insulin Combination therapy of this drug with insulin is used in patients with secondary failure, and is used when fasting blood glucose (FBG) exceeds 150 mg/dL. Administer 8 mg of this drug once daily with the first meal, and initiate insulin at a low dose, increasing it approximately weekly according to fasting blood glucose measurements. Once stabilized, capillary blood glucose should be monitored daily whenever possible. Insulin doses need to be adjusted periodically while measuring blood glucose and glycosylated hemoglobin. 2) Combination therapy with metformin If the patient does not respond adequately to the maximum dose of this drug, addition of metformin may be considered. Published clinical information is available on combination therapy of metformin with other sulfonylureas such as glyburide, glipizide, chlorpropamide, and tolbutamide. When this drug is used in combination with metformin, the desired blood glucose level may be achieved by adjusting the dose of each drug. However, efforts should be made to determine the minimum effective dose of each drug for blood glucose control. There is a risk of hypoglycemia with concomitant administration of this drug and metformin, and the risk may increase. Appropriate caution should be exercised.

Ingredients

Manufacturer
Withers Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of glycemic control in type 2 diabetes mellitus

View approved original text

This medication is used to assist in controlling blood sugar in patients with type 2 diabetes. It is administered as an adjunct to diet and exercise therapy and can also be used alone. If blood sugar control is not well managed with oral hypoglycemic agents alone, it can be combined with insulin. Additionally, it is administered in combination with metformin when sulfonylureas or metformin monotherapy is ineffective. This medication helps improve blood sugar control.

How to take

Adult dose

Adjust the dose individually for each patient. Swallow without chewing with at least 1/2 cup of water. This drug is administered orally once daily. This drug should be taken before breakfast or immediately before the first meal. It is very important not to skip a meal after taking this drug. 1. Monotherapy 1) Initial dose and dose titration In patients who have not previously received medication, initiate treatment with glimepiride 1 mg once daily. If necessary, increase the dose by 1 mg at intervals of 1 ~ 2 weeks. In general, doses above 4 mg provide little additional benefit, but some patients have achieved better metabolic control by increasing the dose to 6 mg (or 8 mg). If treatment with 4 mg daily is unsuccessful, first consider switching to insulin therapy; otherwise, consider combination treatment with insulin or another oral antidiabetic drug. 2) Subsequent dose adjustment As diabetes control may improve as treatment progresses, the requirement for this drug may decrease. Therefore, dose reduction or discontinuation of this drug may be necessary to avoid hypoglycemia. Dose adjustment should also be considered if weight loss, lifestyle changes, or other factors that may increase the risk of hypoglycemia or hyperglycemia occur. 3) Switching from another oral hypoglycemic agent to this drug There is no precise dose equivalence between this drug and other oral hypoglycemic agents. When switching from another oral hypoglycemic agent to this drug, it is recommended to follow the method described under Initial dose. That is, initiate treatment with 1 mg once daily and adjust the dose at 1 ~ 2-week intervals. Consider the potency and duration of action of the previously administered drug. 4) Dose monitoring During treatment with this drug, blood glucose and/or urine glucose levels should be measured regularly; regular measurement of glycosylated hemoglobin (HbA1c) levels is also recommended. In general, hypoglycemia is promptly controlled by immediate ingestion of sugar. Hypoglycemia may recur despite successful initial management during treatment with a sulfonylurea. Therefore, patients should be monitored carefully. Severe hypoglycemia requires immediate medical treatment and follow-up, and hospitalization is sometimes required. 2. Combination therapy 1) Combination therapy with insulin Combination therapy of this drug with insulin is used in patients with secondary failure, and is used when fasting blood glucose (FBG) exceeds 150 mg/dL. Administer 8 mg of this drug once daily with the first meal, and initiate insulin at a low dose, increasing it approximately weekly according to fasting blood glucose measurements. Once stabilized, capillary blood glucose should be monitored daily whenever possible. Insulin doses need to be adjusted periodically while measuring blood glucose and glycosylated hemoglobin. 2) Combination therapy with metformin If the patient does not respond adequately to the maximum dose of this drug, addition of metformin may be considered. Published clinical information is available on combination therapy of metformin with other sulfonylureas such as glyburide, glipizide, chlorpropamide, and tolbutamide. When this drug is used in combination with metformin, the desired blood glucose level may be achieved by adjusting the dose of each drug. However, efforts should be made to determine the minimum effective dose of each drug for blood glucose control. There is a risk of hypoglycemia with concomitant administration of this drug and metformin, and the risk may increase. Appropriate caution should be exercised.

Precautions

This medication should not be used in patients with insulin-dependent diabetes or in those with diabetic ketoacidosis or in a comatose state. Furthermore, individuals who have had allergic reactions to this medication or its components should avoid taking it. There is no experience using this medication in patients with severe liver or kidney dysfunction, so switching to insulin treatment is recommended. It is also safe to avoid taking this medication during pregnancy or in women who could become pregnant and while breastfeeding. Patients with severe infections, or those undergoing surgery, should avoid using this medication as insulin treatment may be necessary. Those with gastrointestinal disorders such as diarrhea or vomiting should be cautious as absorption of food may be impaired, increasing the risk of hypoglycemia. This medication contains lactose, so individuals with lactose intolerance or specific genetic issues should not take it. During the first week of treatment, there is a heightened risk of hypoglycemia, so blood sugar should be checked frequently and observed carefully. Particularly, older adults, patients who are in poor nutritional status or eat irregularly, and those who frequently consume alcohol should be careful as they have a higher risk of hypoglycemia. Patients with impaired kidney or liver function may also respond more sensitively to this medication, necessitating dose adjustments. There may also be an increased risk of hypoglycemia in those with other endocrine disorders or who are taking multiple medications, so caution is warranted. Symptoms of hypoglycemia may include headache, severe hunger, nausea, fatigue, confusion, drowsiness, and in severe cases, loss of consciousness, so it is important to respond immediately to any abnormal symptoms. When first starting or changing doses, symptoms such as blurred vision or dyspepsia may occur temporarily. Regular testing is needed as liver function abnormalities or changes in blood cell counts may occur. If allergic reactions such as itching, rash, or difficulty breathing occur, inform a physician immediately and discontinue the medication if severe. It is important to maintain dietary and exercise regimens while taking this medication and regularly check blood sugar levels. If hypoglycemia occurs, quick ingestion of foods containing sugar is necessary to raise blood sugar rapidly, and it is advisable always to carry sugar. When taking this medication with others, drug interactions may affect blood sugar control, necessitating notification to the doctor or pharmacist of all medications being taken. Pregnant or breastfeeding women should avoid taking this medication and it is safer to switch to insulin treatment if necessary. In children, the safety and efficacy of this medication have not been established so it is best not to use it. Elderly patients should be careful about dose adjustments due to reduced drug clearance from impaired kidney function. In case of overdose, severe hypoglycemia may occur, requiring immediate medical attention.

Side effects

Hypoglycemia, headache, severe hunger, nausea, vomiting, fatigue, sleep, sleep disorders, anxiety, aggressiveness, decreased concentration, decreased agility or activity, depression, confusion, speech abnormalities, aphasia, visual impairment, tremors, incomplete paralysis, sensory abnormalities, dizziness, weakness, loss of self-control, temporary mental confusion, cerebral seizures, drowsiness, loss of consciousness, coma, shallow breathing, bradycardia, sweating, cold and clammy skin, tachycardia, hypertension, palpitations, angina, deep vein thrombosis, blurred vision, fullness or pressure in the upper abdomen, abdominal pain, diarrhea, increased liver enzymes, liver dysfunction, bile secretion disorders, jaundice, hepatitis, thrombocytopenia, leukopenia, hemolytic anemia, erythrocytopenia, neutropenia, agranulocytosis, pancytopenia, itching, hives, rash, shortness of breath, hypotension, shock, anaphylaxis, angioedema, mucocutaneous syndrome, allergic vasculitis, photosensitivity reactions of the skin, decreased serum sodium concentration, taste disorders, hair loss, weight gain, dizziness, liver dysfunction, abdominal pain, arthralgia, dyspepsia, facial edema, erectile dysfunction, flushing of the face, gastritis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air or moisture, so it should be stored in a tightly sealed container. It is important to keep the storage temperature between 1 degree to 30 degrees Celsius at room temperature. By storing it this way, the medication's efficacy and safety can be well maintained.

Appearance and packaging

Appearance

Green oval tablet

Package unit

30 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.